Expert support throughout the complete clinical supply project
In-house sourcing specialists, plus a global network for access to virtually any product
Full-service, vertical, integrated operations for clinical trials – Phase 1 to Phase IV
Advanced technologies and custom solutions to advance your timelines and enhance branding
Seamless supply chain management, cold chain distribution, global shipping and tracking.
Web-based, fully collaborative platforms for keeping clients informed and updated.
Customized, cost-effective aseptic processing for more accurate dosing
Innovative, advanced solutions for immediate and modified release
Innovative options for single dosage, enhanced with custom packaging and in-house design
75 years of first-class manufacturing expertise from the innovators of softgel capsules
Customized sterile solutions for fill-finish, injectable, and needle-safety technologies
Improve pregastric absorption and compliance with our no. 1 oral distintegrating tablet
Our one central supply chain frees capital, ensures highest quality, and speeds time to market
Browse our integrated services for your product's entire lifecycle
Two joint ventures in China for Softgel Technologies and Clinical S...
Advanced Technology for the Development of Optimized Antibody Drug...
OptiMelt™ hot melt extrusion can enhance bioavailability of your po...
As innovators of softgel technology, we offer integrated services a...
Deeper pharmaceutical and biopharmaceutical expertise with global r...
Our talent and expertise can solve the most complex bioavailability...
Our unique, reliable gene retrovector that generates stable mammali...
We can help build you a smooth path from cell line development to product delivery
Customized, specialty fill-finish solutions that drive the most efficient patient outcomes
An overview of our reliable global clinical supply services
Enhance your brand image with consumers preferred delivery systems
Complete range of capabilities for tablets & capsules – from development to supply
Energy, beauty, and well-being all in a capsule
Comprehensive services from dosage form and formulation to clinical trial and packaging
Explore how we can help optimize the therapeutic profiles of your treatments.
Expert development and manufacturing solutions with a competitive edge
Expert support from dosage form selection to clinical and commercial-scale manufacturing
Over 75 years of customizing innovative manufacturing and packaging solutions
Comprehensive development support as well as clinical and commercial-scale manufacturing
New API screening that provides the most stable crystalline form for 500+ compounds
Enabling IV to Oral Conversion of Macromolecules
Enabling Abuse Deterrence in RP Scherer Softgel
A smaller, easy to swallow softgel with the added benefit of dose titration
Expanding the range of fill formulations into softgels
A novel technology in controlled release design that helps improve therapeutic profiles.
An in-house product development program of which some products are available for license.
The latest in fill-finish process, advanced needle safety, and specialty auto-devices
Standard/custom preclinical and clinical testing services – placebos to controlled drugs
Expertise from process design to regulatory support for virtually any sterile dosage form
Customized oral solids development and manufacturing to your most stringent requirements
Our proprietary plant-derived shell for semi-solid compounds, by the softgel innovators
Our unique, solid, oral dosage that dissolves instantly in mouth, enhancing absorption
Bracketing, FMEA , tracking, frequency, along with the introduction of randomized media fills.
A detailed understanding of the material science of the tablet structure
The first-ever survey investigating patient experiences with clinical trial materials
Innovative biotechnology company exploring therapeutics for neuroscience indications
Proven, acceptable NMR spectroscopy test for common EMAs in raw materials and APIs
Development procedures to reduce antibody effect on Protein Z, with validation results
Determination of residual solvents in API by headspace GC-MS needs multiple analyses
Validate method for determination of extractable & leachable silicone oil
Rapid development model for formulation feasibility & accelerated stability evaluation
Robust options available for micro-dosing inhalation powders with some important caveats
Study investigates design using synthetic molecule recognizing immunoglobulin in serums
Why oral disintegrating tablets are so important to the industry’s oral dose form kit
Study on the impact of emulsion liposomal liquid and lyophilized liposomal formulations.
Effect of a Kollicoat Top-coat on the physical stability of enteric-coated softgels
Advanced cosmeceutical formulation needs with DelPouch® and Vegicaps®
Novel approach to validate a method for the determination of water content
Fish gelatin support of nanoparticle formation of poorly water-solubles during wet milling
General review of Catalent’s new technology that optimizes API and profitability
Validate responsive ELISA for the detection of IPZ in monkey, rat, and human serum fluid
Feasibility of encapsulating the Phosphatidylcholine-based excipients.
Study shows import plasticizer level, & potential for migration from coating to shell
Laser diffraction particle size analysis – a robust and efficient alternative
Method to separate un-derivatized protein Z (uTPZ) from derivatized TPZ in 3 species
New shell and hot-filling that are highly viscous or semi-solid at room temperature
Approach to validate from preclinical development to final commercial implementation
Catalent expert, Mike Merges, explores practical considerations for bioassays.
Explore overcoming challenges in the tech transfer of biopharma products.
Removal of impurities is critical in the purification process for production of final products.
This presentation focuses on improving oral delivery for poorly soluble/permeable drugs.
Absence of evidence is not evidence of absence.
Explore the continuing role of NMR Spectroscopy in characterization of specialty polymers
Investigate the relationship between poorly-soluble drugs and disintegration time of (ODTs)
Evaluate the pharmacokinetic behavior of nanosized fenofibrate administered orally
Disintegration and dissolution characteristics of novel, polysaccharidebased shell softgels
Determination of elemental impurities in support of USP <232> and <233>
Development of digestion methods for determination of elemental impurities
Development and validation of a method for determination of bismuth
Explore the power of dual detection methods to identify impurties.
An overview of stability studies during drug product lifecycles.
New data shows drug delivery has a positive impact on patient compliance.
As the use of “universal” HPLC detectors and charged aerosol detectors become more common
New study shows superior patient compliance with oral fast dissolve delivery
Presentation on ensuring viological safety of biologicals
New strategies in formulation development are helping overcome molecule challenges
Softgel Technology as a Lipid-Based Delivery Tool for Bioavailability Enhancement
The aseptic blow-fill-seal (B/F/S) systems have experienced growth.
Presentation detailing inhaled products as well as emerging technologies in this area
Selection of a solid-state form is an important decision in development of small molecule API's
Use of Peptides in Anti-Aging Cosmetology
Providing a definition for virus safety is nebulous at best.
This article looks into current problems in assuring virological safety of biopharmaceuticals.
A comparison between GPEx® and traditional cell line engineering technology.
Explore recent advances in regards to tablet technologies.
Key considerations for selection, benefits, limitations, and future prospects.
Specialized analytical and formulation tools aid in successful, timely Development of LBDDS.
This presentation discusses challenges when considering LBDDS.
The more efficient a bioassay method transfer, the faster to regulatory submission
2009 European study why choosing softgels can impact lifecycle management and marketing
VP of global sales overviews drug delivery technologies and services as well as key trends
Why companies are looking for partners, how the process works, and looking out for a CRO
Implications of FDA release and responsive technologies available to the manufacturer
How manufacturers can partner with contract packagers in new and increasingly complex ways
Modern healthcare challenges and predictions for pharmaceutical market growth
How to make the decision to outsource, navigate vendor selection, and monitor results
VP of business development discusses blow/fill/seal market and offerings
Catalent experts talk about the increasing demand of prefilled syringes
‘Lean’ is a familiar term in European manufacturing since markets are more competitive
Prefilled Syringes Pinpoint Stability, Compatability, and Safety
Exploration of the largest trends in the prefilled syringe and autoinjection devices
Smarter Solutions. Better Adherence. Improved Results.
Catelent CEO John Chiminski discusses our offerings
Focuses on new innovation drug delivery devices for patient-administered therapies
Advances in medical discoveries are for nothing if the medicine isn't taken.
Discussion around the latest trends and issues involving solubility.
Catalent executive discusses excellence in compliance in Pharmaceutical Formulation & Quality
This presentation deals with the challenges of using suppliers from around the globe
VP of Corporate Strategy and Development discusses emerging drug-delivery technologies.
This presentation explores market intelligence.
Learn about how talent and technology can help grow a company.
Integrating quality by design into sterile manufacturing facilities is becoming more important.
Catalent expert discusses how Catalent is becoming a one-stop shop for global customers.
Project management is becoming more important as companies increase outsourcing.
Catalent expert interviewed at INTERPHEX 2011 about the blow/fill/seal process.
Catalent expert Mike Jenkins explains the change Catalent's facility is making.
Bend Research and Catalent enter into an agreement to provide integrated solutions.
An interview with Catalent's Scott Houlton.
CMOs share their opinions on the prospects for their businesses.
In today's enviroment solution providers are preferred over CMO's.
Explore a cGMP manufacturing model for reducing operating costs and speeding up drugs to market
The striking efficiency gains Catalent has achieved with the Lean System for Managing
Pros and cons of options, plus discussion of global problems and lack of foreign security
Clinical trials are a critical step in the approval process for new drugs.
Case Study: Marchesini Group for Catalent Pharma Solutions: Efficient Syringe Packaging
This presentation details a case study about a phase III global trial.
From formulation to specialty packaging, this article explores patient adherence.
Explore the issues with technical transfer in regardss to complex pharmaceutical products
This article explores importing clinical trial materials to South America.
How Clinical Supply Management Systems can bring efficiencies to support Project Lifecycle
Selection of the optimal solid form is a critical decision in the development lifecycle.
Global manufacturers are exploring the possibility of producing biosimilars
This webcast will highlight the latest omega-3 drug developments.
Explore and learn about advances in lipid-based drug delivery systems (LBDDS).
Hot melt extrusion is being explored as a way to overcome solubility challenges.
Explore fit-for-purpose strategies in discovery and development of solid-state forms.
A guideline for selecting the best methods to analyze and characterize antibodies.
An introduction to regulatory documents surrounding leachables and extractables.
Examine the current market, industry trends, and discuss the latest technologies.
Address principles and practices of stability studies in the drug development
Unlocking the therapeutic potential of BCS Type II & IV compounds
Regulatory and global trade requirements for shipment into key clinical trial markets.
Learn steps taken to improve timelines and throughput in generation of mammalian cell lines
Discover the future of oral Vitamin D3 analogs
Sourcing Center InvestorsCareersContact UsSite Map
Copyright © 2011, Catalent, Inc - All Rights Reserved | Privacy I Terms